Danis Pharma
ActiveSummary
Danis Pharma has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €784,088 and a net result of €71,707. Equity is growing by ~15.3% per year across the filed fiscal years. Its solvency ranks better than 95% of 12396 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 5 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23003A0237/00E010 | Flanders | 784 m² | 1 · 114 m² | 12.5 m · 3 fl. |